Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis

Liver-related diseases are the third-leading causes (9.3%) of mortality in type 2 diabetes (T2D) in Japan. T2D is closely associated with nonalcoholic fatty liver disease (NAFLD), which is the most prevalent chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH), a severe form of NAFLD...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumida, Yoshio, Yoneda, Masashi, Tokushige, Katsutoshi, Kawanaka, Miwa, Fujii, Hideki, Yoneda, Masato, Imajo, Kento, Takahashi, Hirokazu, Eguchi, Yuichiro, Ono, Masafumi, Nozaki, Yuichi, Hyogo, Hideyuki, Koseki, Masahiro, Yoshida, Yuichi, Kawaguchi, Takumi, Kamada, Yoshihiro, Okanoue, Takeshi, Nakajima, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139365/
https://www.ncbi.nlm.nih.gov/pubmed/32168769
http://dx.doi.org/10.3390/ijms21061907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139365/
https://www.ncbi.nlm.nih.gov/pubmed/32168769
http://dx.doi.org/10.3390/ijms21061907

Ejemplares similares